I agree, it doesn't seem right. I would think, a successful development of the flu vaccine and approval from NMPA, would be a much larger payment than $2M. I guess there has to be royalties in there too. Maybe the same $2/dose. Yeah, this one is not clear.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.